California MEPS Hub for HIV prevention and reentry support
Official title: California Hub for HIV/STI/SUD Prevention Research With Reentry Populations
Run by University of California, Los Angeles · NCT07433985 · Data updated 2026-11-12
This project will test a peer-led, app-based program with small cash incentives to help people with substance use recently released from jail or prison get PrEP, HIV/STI testing, and related services.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 59 Years |
| Sex | Men only |
| Enrollment | 318 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 3 sites (Oakland, California and 2 other locations) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | July 31, 2029 |
| Study ends | July 31, 2029 |
| Registry record updated | April 3, 2026 |
| Trial ID | NCT07433985 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people assigned male at birth, aged 18–59, released from jail or prison within the past 12 months, with a history of substance use or recent SUD treatment, recent sexual or injection risk, self-reported HIV-negative status, access to or plans to obtain a smartphone, and intent to reside in the study counties for nine months.
✕Probably not a fit
People already living with HIV, those without smartphone access or unwilling to remain in the study counties, individuals outside the specified age or gender criteria, or those not meeting the recent incarceration or substance use criteria are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study is a Type 3 Hybrid Implementation-Effectiveness trial that aims to adapt and scale the Mobile Enhanced Prevention Support (MEPS) intervention across three community partner organizations in Alameda and Riverside counties. MEPS combines trained peer mentors, a smartphone app (GeoPass), and contingency management (small cash incentives) to promote biomedical HIV prevention and preventive screenings among people with substance use disorders who were recently incarcerated. The trial will enroll at least 300 participants, with the first 200 randomized to intervention or control and the final 100 receiving the intervention in a single-arm continuation, alongside implementation-focused data collection from partner staff. The primary emphasis is on implementation outcomes and tailoring MEPS for broader settings, with effectiveness (e.g., PrEP uptake and testing) as a secondary aim.
Why it matters
Potential benefit: If successful, MEPS could increase PrEP uptake, routine HIV/STI/HCV testing, and engagement with prevention and substance use services among people reentering the community after incarceration.
How similar studies have gone: A prior randomized trial in Los Angeles showed MEPS increased PrEP uptake and HIV testing among English-speaking participants, but applying and adapting the package across diverse agencies and populations is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: RCT Participants * Assigned male at birth * Ages 18 - 59 * Was released from incarceration in the previous 12 months (incarceration is defined as a stay in jail, prison, or detention centers for over 24 hours) * Reports an SUD diagnosis or seeking SUD services at any time in the 24 months prior to enrollment * During the 24 months prior to enrollment, either: 1. Reports intercourse with a person assigned male at birth 2. Reports injection drug use * Has not received an HIV diagnosis (based on self-report) * Possesses a smartphone or plans to obtain one * Plans to reside within designated jurisdictions (counties) for the 9 months following enrollment CBO and agency staff participating in implementation surveys or interviews * \>=18 years of age * Employed at a study site or otherwise involved with intervention implementation and/or maintenance OR works at an agency in the counties where the study is taking place (Los Angeles, Riverside, San Bernardino, and Alameda counties, California). * Willing to provide informed consent for participation. Exclusion Criteria: RCT Participants: * Does not have a smart phone and is not willing to obtain one * Is not able to speak and understand English * Has insufficient reading skills to operate a mobile application on a cell phone CBO participating in implementation interviews \- n/a
Where it's running
-
Cal-Pep
Oakland, California, United States Recruiting -
Kindful Restoration
Riverside, California, United States Recruiting -
Starting Over, Inc
Riverside, California, United States Recruiting
Study contacts
- Study coordinator: Study Director
- Email: camepshub@mednet.ucla.edu
- Phone: 424-501-4829
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
Real-time fMRI Neurofeedback for Anhedonia in Methadone-Treated Opioid Use Disorder
This feasibility study tests a real-time fMRI neurofeedback approach to see if it helps reduce anhedonia in people on methadone for opioid use disorder.
-
Trauma recovery options for veterans: comparing HRV biofeedback and present-centered therapy
This trial tests whether Heart Rate Variability Biofeedback plus trauma-informed care helps veterans with PTSD and substance use issues more than present-centered therapy.
-
Connecting Loved Ones to Support and Empower Recovery
A web-based program called KulaMind-Recovery tests whether guided online training, one-on-one coaching, and a community forum help loved ones support someone with a substance use disorder.
-
Next-Generation Dome Helmet for Focused Ultrasound Neuromodulation in Treatment-Resistant Substance Use Disorder
This study tests whether focused ultrasound delivered through a Dome Helmet can be safely used to target brain regions and help adults with hard-to-treat substance use disorders see if their use declines.
-
Pharmacist-guided PEP/PrEP Access Using PEPPI Software
This trial tests whether the PEPPI software helps pharmacists provide PEP/PrEP and helps patients access these HIV prevention options.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.